SLC5A2 and nephrolithiasis: Moreover, 731 patient-pairs with a history of nephrolithiasis and similar baseline characteristics suffered from recurrent urolithiasis; the recurrence-free time was a little longer in the SGLT-2 inhibitor cohort (1,485 vs 1,386 person-years).